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Bentall procedure, involves excision of the aneurysm,
implantation of a composite valve graft with direct
attachment of the coronary arteries as buttons into the
aortic graft and anastomosis of the graft distally to the
divided aorta.2 Woven polyester has become the mater-
ial of choice for most surgeons for prosthetic aortic
replacement. Bleeding through the earlier porous grafts
was a particular problem, and the classic inclusion tech-
nique was specifically designed to cope with this by
making use of the aneurysm sac as a wrap-around to
tamponade graft leakage. Grafts that required preclot-
ting with albumin or blood have now been superceded
by woven polyester impregnated with either collagen or
gelatin,3,4 resulting in a prosthesis resistant to blood
leakage through its interstices, one described as having
ultra-low porosity.
More recently, composite prostheses for replacing the
aortic root have become commercially available, and
one such composite conduit is the Carbo-Seal ascend-
S ince Bentall and De Bono’s first description of theuse of a composite graft and valve for the complete
replacement of an ascending aortic aneurysm and aortic
valve,1 both the techniques of implantation and the
types of valve and graft used have evolved. The cur-
rently preferred implantation technique, a modified
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ing aortic prosthesis (Sulzer Carbomedics, Inc, Austin,
Tex). The prosthesis combines a bileaflet CarboMedics
prosthetic heart valve with a gelatin-impregnated,
woven polyester graft. There is minimal tapering
between the valve and the graft, which facilitates coro-
nary implantation, especially where coronary mobiliza-
tion is difficult (eg, in redo cases). The graft is retained
by the titanium stiffening ring of the valve (Fig 1). The
impregnation of the graft with gelatin confers ultra-low
porosity and apart from simple washing, the graft needs
no special treatment before implantation. The aim of
this study was to retrospectively review the cases of all
patients who underwent aortic root replacement with
the Carbo-Seal prosthesis at two surgical centers in the
United Kingdom and to determine risk factors for early
mortality and the prevalence of early morbid events, as
well as the intermediate term survival and freedom
from reoperation.
Patients and methods
Between August 1992 and March 1997, 143 consecutive
patients underwent aortic root replacement with the Carbo-
Seal ascending aortic prosthesis at the Wessex Cardiothoracic
Centre, in Southampton, United Kingdom (76 patients), and
the Queen Elizabeth Hospital, in Birmingham, United
Kingdom (67 patients). The indication for a Carbo-Seal pros-
thesis implantation was all patients requiring aortic root
replacement, excluding those with an absolute contraindica-
tion to anticoagulation and those with an aortic root abscess
in whom a homograft aortic root was used. The mean age of
the patients was 56.4 ± 15.8 years (1 SD). There were 112
males (78%) and 31 females (22%), and Marfan syndrome
was present in 27 (19%). Preoperatively, 58 patients were in
New York Heart Association (NYHA) functional class I
(40%), 28 in class II (20%), 36 in class III (25%), and 21 in
class IV (15%). The diagnosis was made by means of a com-
bination of echocardiography, aortography, and computed
tomographic and magnetic resonance imaging, depending on
the degree of urgency and local availability. Coronary
angiography was undertaken in 92 patients (64%), though
not in those with acute dissection or young patients without
risk factors for coronary artery disease. Annuloaortic ectasia
(comprising dilatation of the aorta at valve and sinus level
and cephalad migration of the coronary ostia) was consid-
ered to be present in the 27 patients with Marfan syndrome
and in a further 85 patients with histologic evidence of cys-
tic medial degeneration. The indications for surgery are
given in Table I. The four patients classified as having a
redissection had all previously undergone ascending aortic
replacement with an interposition graft for aortic dissection
and had subsequently redissected in the proximal aorta,
resulting in aortic regurgitation. Of the 3 patients with a false
aneurysm, 1 had undergone a total of 5 aortic valve replace-
ments for infective endocarditis, 1 had undergone an aortic
root replacement 7 years previously, and the third had under-
gone repair of a type A dissection and resuspension of the
aortic valve 4 years earlier.
Twenty-seven patients (19%) had undergone previous car-
diac surgery requiring sternotomy. Aortic valve replacement
(AVR) had been undertaken in 15 patients, aortic root replace-
ment in 5, an ascending aortic interposition graft in 5, AVR
and coronary artery bypass grafting in 1, and correction of
tetralogy of Fallot in 1. Ten of the 40 patients (25%) with type
A dissection had undergone previous aortic valve or ascend-
ing aortic surgery. Concomitant procedures were undertaken
in 38 patients (27%). Twelve patients underwent aortic arch
replacement, and concomitant hemiarch replacement was
undertaken in 6, coronary artery bypass grafting in 13, and
other procedures in 7. Surgery was undertaken as an emer-
gency in 40 patients (28%), on an urgent basis (the next avail-
able operating list) in 17 (12%), and electively in 86 (60%).
Operative details. A total of 143 patients underwent aor-
tic root replacement with the Carbo-Seal ascending aortic
prosthesis by a modification of the Bentall technique.1 Tight
wrapping of the aortic aneurysm sac around the graft was not
done owing to its association with late complications,5 but
loose wrapping was used occasionally as an aid to hemosta-
sis. Redundant aortic tissue was excised, and the distal anas-
tomosis was made to the divided aorta. Coronary reimplanta-
tion was performed by using the button technique6 for 140
patients, by the inclusion technique for 2 patients, and by the
Cabrol technique for 1 patient.7 The prosthesis has an ade-
Fig 1. Incorporation of the graft into the valve housing.
Table I. Indication for operation
Indication for operation No. of patients (%)
Ascending aortic aneurysm 100 (70)
Acute type A dissection 27 (19)
Acute type A redissection 4 (3)
Chronic type A dissection 9 (6) 
False ascending aortic aneurysm 3 (2)
Total 143
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quate sewing cuff as well as a graft that is easy to suture and
does not fray when the coronary ostia are fashioned with a
battery-operated cautery device.
The diameter of the aortic anulus determines the size of the
prosthesis implanted. For valve sizes 21 to 31, the graft inner
diameter is 3 mm larger than the valve size, and for a pros-
thesis with a valve size of 33 mm, the graft size is 34 mm. In
this series a prosthesis with valve size of 23 mm was implant-
ed in 27 patients (19%), size 25 was used in 54 patients
(38%), size 27 in 30 patients (21%), and size 29 in 32 patients
(22%). Gelatin-resorcin-formaldehyde tissue glue was used
in 78 (55%) of cases. It was used in all patients with acute
aortic dissection to facilitate apposition of layers of the dis-
sected aorta at the distal anastomosis and in other cases to
cover the anastomotic suture lines as determined by the indi-
vidual surgeon’s preference. The mean duration of cardiopul-
monary bypass was 129 ± 49 minutes, the mean ischemic
time was 88 ± 29 minutes, and a variety of perfusion tech-
niques were used. The femoral artery was cannulated in 127
patients (89%), the distal ascending aorta in 16 (11%).
Venous return was established via the right atrium in 125
patients (87%) and the femoral vein in 18 (13%). Cold crys-
talloid potassium cardioplegic solution was given antegrade-
ly in 137 (96%) and retrogradely in 6 patients. Moderate
hypothermia (28°C) was used in 84 patients (59%). Deep
hypothermia (15°C-18°C) with circulatory arrest was used in
59 patients (41%). It was always used in patients undergoing
repair of acute dissection or aortic arch surgery. The mean
duration of circulatory arrest was 26 ± 14 minutes.
Retrograde cerebral perfusion was used in 45 of these
patients, with a mean duration of 23 ± 14 minutes. Aprotinin
was used in 57 cases (40%).
All patients received anticoagulation with warfarin. This
was commenced on the evening of the first postoperative day.
The international normalized ratio (INR) was maintained
between 2.5 and 3.5. If the INR had not reached the therapeu-
tic range by day 3 postoperatively, then intravenous heparin
was commenced and the activated partial thromboplastin ratio
was also maintained between 2.5 and 3.5. Anti-platelet medi-
cation was not routinely prescribed. After patients were dis-
charged from the hospital, their clinical status was obtained
either from outpatient clinic visits to the hospital or by direct-
ly contacting the patient’s family doctor by letter and ques-
tionnaire. The total follow-up was 270 patient-years. Follow-
up was 100% complete.
Statistical analysis. All continuous data are expressed as
mean ± 1 SD or median ± interquartile range; categorical
variables are reported as a percentage; a commercial statisti-
cal software package (SPSS for Windows, version 8.0, SPSS
Inc, Chicago, Ill) was used for data analysis. A total of 26
preoperative and operative variables were analyzed for their
possible influence on early mortality (defined as occurring
within 30 days of operation or anytime before discharge). The
preoperative variables were age, sex, previous cardiac
surgery, preoperative NYHA class, cardiac rhythm, creati-
nine, presence of a pericardial effusion, left ventricular func-
tion, urgency of surgery, and indication for surgery. Operative
variables included the operating surgeon, arterial and venous
cannulation sites, type of cardioplegia, valve size implanted,
use of tissue glue, aprotinin, lowest temperature, use of cir-
culatory arrest, retrograde cerebral perfusion, concomitant
procedure, aortic crossclamp and cardiopulmonary bypass
time, use of an intra-aortic balloon pump, blood loss in the
first 24 hours, and length of stay on the intensive care unit.
Variables were first tested individually in a univariate logistic
regression analysis. Subsequently, covariates found to be
either significant (P < .05) or possibly significant (P < .2)
were then entered into a multivariable logistic regression
model. Survival and freedom from reoperation probability
estimates were determined by Kaplan-Meier actuarial analy-
sis; variability was expressed as ± 1 SEM. 
Results
Early mortality. The early (30-day) mortality was
7% (10 patients). The causes of death are detailed in
Table II. Of these 10 patients, 6 had undergone emer-
gency surgery for acute type A dissection, 6 had under-
gone previous aortic or cardiac surgery, 7 had a con-
comitant procedure, and 6 were in NYHA class IV
preoperatively. Three patients had acute myocardial
infarction, resulting in early death. In no case was this
related to technical problems with the coronary anasto-
moses. Two of these patients had severe underlying
coronary artery disease. One had an acute infarction
peroperatively and could not be weaned from car-
diopulmonary bypass. The other had an unheralded MI
19 days postoperatively. The patient’s INR on the pre-
vious day was 3.2. The third patient who died of an
acute myocardial infarction had received 5 g of tranex-
amic acid peroperatively, and acute coronary ostial
thrombosis developed 12 hours postoperatively. The
patient presented in cardiac arrest, and despite rapid
institution of resuscitation, including commencement
of cardiopulmonary bypass and coronary artery bypass
grafting, the patient died. Six factors were found to be
Table II. Causes of early mortality
Day Sex Age Cause of death
DOT M 74 Acute cardiac failure
DOT M 59 Acute myocardial infarction
12 hours F 49 Acute myocardial infarction
1 M 68 Acute cardiac failure
5 M 66 Ruptured abdominal aortic aneurysm
7 M 74 Stroke from atheromatous embolism
8 M 80 Multiorgan failure
9 F 74 Multiorgan failure
15 M 71 Sepsis
19 M 70 Acute myocardial infarction
DOT, Death on table.
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significantly associated (P < .05) with early death
(Table III). By multiple logistic regression, however,
only cardiopulmonary bypass time was found to be
associated with increased early mortality in the pres-
ence of the other factors (P = .03). The odds ratio for
cardiopulmonary bypass time was 1.0236 (95% confi-
dence interval 1.0022 to 1.0456).
Early morbidity. Postoperative complications devel-
oped in 68 patients (47.6%). There were a total of 83
early morbid events in this group (Table IV). Of the 14
patients returned to surgical theater because of bleeding,
a “surgical” source was identified in only 3 and in no case
was the bleeding related to the prosthesis. The mean
blood loss through the drains in the first 24 hours was 720
± 552 mL. There were 3 permanent neurologic compli-
cations, all of which were present at extubation, compris-
ing 2 patients with hemiplegia and 1 with mild left arm
weakness. Two patients had a transient ischemic attack,
with transient upper limb weakness developing shortly
after extubation on the first postoperative day. In both
cases the deficit fully recovered within a few hours, and
neither patient has had any further episode. Respiratory
failure, defined as a need for mechanical ventilation for
more than 24 hours, occurred in 11 patients. Two patients
who required hemofiltration because of acute tubular
necrosis made a full recovery. Both patients who suffered
sternal dehiscence had developed a wound infection with
methicillin-resistant Staphylococcus aureus. One healed
after undergoing sternal resuture and wound irrigation;
the other required an omental transposition. Six patients
had a pyrexia of unknown origin develop. This diagnosis
was made only when repeated cultures of sputum, urine,
wound, and blood were negative, the white cell count was
not elevated, echocardiographic appearances were nor-
mal, and the patient was clinically well. The median
intensive care unit stay was 1 day (interquartile range, 1-
2 days). Median hospital stay was 11 days (interquartile
range, 8-16 days).
Late results. The mean duration of follow-up was 23
± 17 months (maximum, 56 months). Of the 126 surviv-
ing patients, 119 (94.4%) are in NYHA class I, with the
remaining 7 (5.6%) in NYHA class II. There were 7 late
deaths. The causes of the deaths of these patients are
detailed in Table V. Four patients died of cerebrovascu-
lar accident (CVA). One of these patients had a perma-
nent CVA develop perioperatively. The patient was sub-
sequently transferred home, where he died 5 months
later. The other 3 patients whose cause of death was
CVA did not have a peroperative CVA and died at other
hospitals; unfortunately, none of them underwent autop-
sy. The 46-year-old man who died as a result of intracra-
nial bleeding had this diagnosed on postmortem exami-
nation. Finally the 44-year-old man who died 12 months
postoperatively had undergone 4 previous aortic valve
Table III. Risk factors for early death 
No 
Early death early death 
Risk factor (n = 10) (n = 133) P value
Age (y) 68.5 ± 8.9 55.4 ± 15.8 .023
NYHA class IV 60% 11% <.001
Creatinine (mmol/L) 131 ± 44 105 ± 28 .014
Concomitant procedure 70% 23% .004
Cardiopulmonary 203 ± 79 123 ± 42 <.001
bypass time (min)
Emergency surgery 60% 21% .011
Data for continuous variables are given as mean ± standard deviation;
categorical variables are reported as a percentage.
Table IV. Early morbidity
Early morbidity No. of patients
Cardiac complications 46
Atrial fibrillation or flutter 18
Returned for bleeding 14
Permanent pacemaker 8
Pericardial effusion requiring drainage 6
Neurologic complications 7
Cerebrovascular accident (permanent) 3
Cerebrovascular accident (temporary) 2
Transient ischemic attack 2
Respiratory complications 16
Respiratory failure 11
Bronchopneumonia 4
Pleural effusion requiring drainage 1
Renal complications 2
Hemofiltration (temporary) 2
Wound complications 4
Sternal dehiscence 2
Wound infection 2
Fever of unknown origin 6
Gastrointestinal bleeding requiring laparotomy 1
Recurrent laryngeal nerve palsy 1
Table V. Causes of late mortality
Age/Sex Mo Postmortem Cause of death
1. 70 Male 2 No Cerebrovascular accident
2. 74 Male 5 No Cerebrovascular accident
3. 46 Male 5 Yes Intracranial bleeding
4. 76 Male 10 No Multisystem failure 
following redo for 
endocarditis
5. 76 Male 12 No Cerebrovascular accident
6. 44 Male 12 No Myocardial failure
7. 79 Male 29 No Cerebrovascular accident
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replacements for endocarditis and a homograft aortic
root replacement before his Carbo-Seal aortic root
replacement. The indication for the Carbo-Seal aortic
root replacement was a false aneurysm. He had a long
history of alcohol abuse and was in NYHA class III as a
result of alcoholic cardiomyopathy. He was seen, mori-
bund, 12 months after the Carbo-Seal implantation, and
transesophageal echocardiography demonstrated a small
leak from around the right coronary button. There was
no evidence of valve dysfunction. In view of his history
and moribund condition, further surgery was not thought
appropriate. Including early mortality, survival was
90.1% ± 2.6% (1 SE) at 12 months, 87.9% ± 3.0% at 24
months, and 83.1% ± 4.4% at 48 months (Fig 2).
Freedom from reoperation was 97.2% ± 1.6% (1 SE) at
12 months and 95.7% ± 2.2% at 48 months (Fig 3). Four
patients have undergone reoperation:
1. A 30-year-old man had infective endocarditis
develop 117 days postoperatively and underwent a
homograft aortic root replacement. He is currently
alive and well and in NYHA class I.
2. A 71-year-old woman in whom a false aneurysm
developed at the distal aortic suture line 153 days post-
operatively, which necessitated repair on cardiopul-
monary bypass though the prosthesis, did not need a
replacement prosthesis. She is currently alive and in
NYHA class II.
3. A 76-year-old man had endocarditis, including a
large aortic root abscess, 256 days after aortic root and
hemiarch replacement. Homografts were used to
replace the root and arch, but the patient died of multi-
system failure 29 days later.
4. A 26-year-old man with Marfan syndrome who
had undergone a classical Bentall operation had a false
aneurysm arising from the right coronary ostium. At
687 days postoperatively, a Carbo-Seal prosthesis was
used with the button technique for the coronary anasto-
moses. He is currently well and in NYHA class I.
With regard to nonfatal valve-related complications,
there were 2 patients who underwent reoperation for
endocarditis, as discussed above. In addition, 3 patients
had amaurosis fugax and began low-dose aspirin thera-
Fig 2. Kaplan-Meier survival curve.
Fig 3. Freedom from reoperation.
py and had no recurrence. There was no other reported
incidence of valve-related complications during fol-
low-up—no valve dysfunction, valve thrombosis,
thrombotic embolism, or bleeding event. 
Discussion
Composite valve and graft replacement of the aortic
root has become the generally accepted surgical tech-
nique for treatment of a variety of proximal aortic con-
ditions, including aneurysm with aortic valve incompe-
tence, aortic dissection, and infective endocarditis.
Controversy exists, however, in the case of both aortic
dissection and aneurysmal dilatation, particularly in
patients with Marfan syndrome. Some favor aortic root
replacement8,9; others advocate the sparing of the aortic
valve leaflets, even when aortic insufficiency is present,
because they believe the valve dysfunction is caused by
dilatation of the sinotubular junction, distortion of the
sinuses of Valsalva, or annuloaortic ectasia.10 Currently,
we elect to replace the entire aortic root, including the
valve, in such patients. No patients in this series under-
went root replacement for treatment of endocarditis
where a homograft would be our choice.
The Carbo-Seal prosthesis was chosen because of the
surgeons’ familiarity with CarboMedics prosthetic
heart valves (Sulzer Carbomedics, Inc). A meta-analy-
sis of CarboMedics prosthetic aortic valves has
revealed excellent functional characteristics in combi-
nation with 5-year freedoms from thrombosis, throm-
boembolism, endocarditis, and reoperation of 100%,
94%, 98%, and 97%, respectively.11 The woven poly-
ester Carbo-Seal graft is impregnated with cross-linked
mammalian gelatin. The gelatin biodegrades by hydrol-
ysis within 14 days. In collagen-coated grafts, howev-
er, the collagen is enzymatically metabolized and the
rate of removal of collagen has been shown to be slow-
er than that of gelatin.3 Previous studies have shown the
gelatin to be nonpyrogenic and to exhibit low thrombo-
genicity. In addition, no inflammatory reaction was
induced, as determined by plasma C—reactive protein
and a 1-acid glycoprotein.3,12 Collagen-coated grafts,
however, have been shown to stimulate an increased
inflammatory response arising from the incompletely
absorbed collagen coating.13 Six patients (4%) had a
fever of unknown origin postoperatively, which
resolved in all of them within 2 weeks. Although this
may be related to an inflammatory response produced
by the gelatin, experimental evidence suggests that this
is not the case,3 and these fevers may reflect mediasti-
nal collections of blood around the graft.
The early mortality in this series of 7% compares
with that of between 5% and 13% in other similar
The Journal of Thoracic and
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series.2,6,14-19 Direct comparison between these series is
difficult, however, as the patient groups vary between
the series. The number of emergencies, dissections,
reoperations, and patients with Marfan’s syndrome all
vary, as do the surgical techniques and prostheses used.
On initial inspection, the incidence of early morbid
events may seem high. In part, this probably reflects
the thorough nature of this study and, in part, the rela-
tively high-risk nature of the surgery itself. The most
important complications from the patient’s standpoint,
however, are those with long-term effects. These
include a permanent pacemaker (8 patients), permanent
neurologic deficit (3 patients), and omental transfer for
sternal dehiscence in a patient with methicillin-resis-
tant S. aureus infection.
Late complications were infrequent, given the com-
plex nature of the surgery. Two patients had endocardi-
tis develop, necessitating replacement of the prosthesis
with a homograft. Two patients had a false aneurysm, 1
at the distal anastomosis, which was repaired without
replacing the aortic root, and 1 from the right coronary
artery button, after a classic Bentall procedure. This has
been reported by others and seems to be associated with
Bentall’s inclusion technique5—probably the result of
tension on the coronary ostial anastomoses resulting
from the wrapping, particularly when blood accumu-
lates within the wrap.14 Our results give further support
to other series advocating the button technique6,17 as no
pseudoaneurysms have developed in the proximal aortic
area when this technique has been used.
Actuarial survival of 83.1% ± 4.4% at 4 years com-
pares very favorably with other series,2,6,18,19 including
those in which higher risk patients, such as with emer-
gency cases, have been excluded.16 Our series, howev-
er, has relatively few patients reaching 4 years’ follow-
up at present. Thromboembolism may occur more
frequently after prosthetic aortic root replacement
when compared with simple aortic valve replacement.
Gott and associates20 found the incidence of minor
thromboembolic and hemorrhagic events to be low
(0.42% per 100 patient-years in a study of 270
patients), whereas Peigh and associates21 reported a
very high incidence of scotoma (50%) in a small group
of patients with valve-conduit replacements. Amauro-
sis fugax was reported to us in 3 cases. None of the 4
patients whose cause of death was given as CVA
underwent autopsy. 
In conclusion, aortic root replacement using the
Carbo-Seal ascending aortic prosthesis is effective treat-
ment for aortic aneurysms and dissections involving the
aortic root, both as a primary procedure and in patients
undergoing a redo operation. The technique of aortic
1020 Langley et al The Journal of Thoracic and
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resection and direct coronary button implantation
results in a relatively low operative mortality and mor-
bidity, together with a high freedom from reoperation.
In that the current study only addresses early and inter-
mediate outcome, continued follow-up will be needed
to determine the long-term efficacy of this prosthesis. 
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